Adjuvant chemotherapy for pregnant breast cancer patients. Case report: 2014/10/13 張嘉顯 1 (PABC; pregnancy-associated breast cancer). - ppt download
Frequency of FAC chemotherapy toxicities by the ECOG grade | Download Table
Neoadjuvant chemotherapy in patients with locally advanced breast cancer: A pilot-observational study
Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect
CAF (FAC) Regimen
Optimizing Adjuvant Chemotherapy in Early-Stage Breast Cancer
Solved 55. The chemotherapy regimen "FAC" during a 21- to | Chegg.com
PDF) Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol) | Semantic Scholar
![PDF] Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d570364e9d16703e6207f32528f8003b40217248/5-Table2-1.png "PDF] Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. | Semantic Scholar")
PDF] Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. | Semantic Scholar
Cancer Chemotherapy | Science
Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy. | Semantic Scholar
NICE Guideline Template
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable
FEC chemo and a cold don't mix - Website for Liz O'Riordan
Docetaxel, Doxorubicin and Cyclophosphamide (the TAC regimen): An Effective Adjuvant Treatment for Operable Breast Cancer - Miguel Martin, 2006
Chemotherapy: actual dose intensity of drugs | Download Table
Metastatic Breast Cancer - Harrisons Manual of Oncology 2nd Ed.
Neoadjuvant chemotherapy in patients with locally advanced breast cancer: A pilot-observational study
Chemotherapy Regimen TAC Improves Survival Over FAC in Early Breast Cancer - CancerConnect
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial - The Lancet
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial - The Lancet
Neoadjuvant chemotherapy in patients with locally advanced breast cancer: A pilot-observational study
Patient characteristics in FAC and TAC regimen with: health-related... | Download Table
Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. - Abstract - Europe PMC
The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer | PLOS ONE
